The Filing Desk

Cerus vs LeMaitre Vascular

Cerus CERS · LeMaitre Vascular LMAT · Health Care Equipment

LeMaitre Vascular reported revenue of $250 million in fiscal 2025, about the same as Cerus' $234 million in fiscal 2025. Cerus' revenue grew 16.1% in its latest year, and LeMaitre Vascular's grew 13.5%. Cerus had an operating margin of -3.7%, against 27.2% at LeMaitre Vascular. Free cash flow was $1 million at Cerus and $74 million at LeMaitre Vascular.

Side by side

CerusLeMaitre Vascular
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$234M$250M
Revenue growth16.1%13.5%
Revenue growth a year, last 5 years15.4%14.0%
Gross margin—71.5%
Operating margin−3.7%27.2%
Net margin−6.7%23.1%
Free cash flow$1M$74M
Free cash flow margin0.5%29.8%
Return on capital—25.5%
Net debt to EBITDA—−2.4x
Dividends and buybacks$0M$20M
Change in diluted share count3.3%0.7%
Last close$1.99$78.29
P/E at the last close—28.5×
Insider trades, last 12 months—sold $30.0 million
Piotroski F-score—5 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
CerusLeMaitre Vascular
Operating margin
Percent of revenue
CerusLeMaitre Vascular
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CerusLeMaitre Vascular

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Cerus and LeMaitre Vascular pages.